Clinical features, management and prognosis of multifocal primary bone lymphoma: A retrospective study of the international extranodal lymphoma study group (the IELSG 14 study)

Carlo Messina, Andrés J M Ferreri, Silvia Govi, Marta Bruno-Ventre, Elías A. Gracia Medina, David Porter, John Radford, Dae S. Heo, Hee Y. Park, Barbara Pro, Jayasingham Jayamohan, Carlo Visco, Lydia Scarfò, Emanuele Zucca, Mary Gospodarowicz, David Christie

Research output: Contribution to journalArticlepeer-review

Abstract

'Multifocal bone lymphoma' or 'polyostotic lymphoma' is a neoplasm with exclusive multifocal involvement of the skeleton, without affecting lymph nodes or other soft tissues. Knowledge on this uncommon condition is limited because the related literature is sparse and fragmentary. We reviewed cases of multifocal bone diffuse large B-cell lymphoma (MB-DLBCL) registered in a clinico-pathological database of the International Extranodal Lymphoma Study Group that includes 499 cases of bone lymphoma. Clinical features, management and prognosis of 37 MB-DLBCL patients and 63 'controls' (stage-IV DLBCL and skeletal involvement) were analysed. Presentation and treatment of MB-DLBCL and controls were identical. At a median follow-up of 52 months (10-189), MB-DLBCL patients exhibited a significantly better response rate (92% vs. 65%; P = 0·002), progression-free survival (5-year: 56 ± 9% vs. 34 ± 6%; P = 0·003) and overall survival (5-year: 74 ± 8% vs. 36 ± 7%; P = 0·002). Among MB-DLBCL patients, the use of post-chemo radiotherapy was associated with better overall survival (5-year: 83 ± 12% vs. 55 ± 16%; P = 0·003). Two MB-DLBCL patients (5·4%) with spine and skull involvement experienced central nervous system (CNS) relapse. Thus, MB-DLBCL patients exhibit a significantly better prognosis compared to patients with advanced-stage DLBCL, and should be treated with conventional anthracycline-based chemotherapy, keeping intensified treatment for relapsing cases, considering involved-field radiotherapy, and CNS prophylaxis in high-risk patients.

Original languageEnglish
Pages (from-to)834-840
Number of pages7
JournalBritish Journal of Haematology
Volume164
Issue number6
DOIs
Publication statusPublished - Mar 2014

Keywords

  • Multifocal bone lymphoma
  • Osteolymphoma
  • Polyostotic lymphoma
  • Primary bone lymphoma

ASJC Scopus subject areas

  • Hematology

Fingerprint Dive into the research topics of 'Clinical features, management and prognosis of multifocal primary bone lymphoma: A retrospective study of the international extranodal lymphoma study group (the IELSG 14 study)'. Together they form a unique fingerprint.

Cite this